Improving Treatment Decisions For Breast Cancer Patients
EDM number 796 in 2013-14, proposed by Rosie Cooper on 26/11/2013.
Categorised under the topics of Diseases and Health services.
That this House welcomes the National Institute for Health and Care Excellence's final guidance on the Oncotype DX breast cancer test; notes that this represents an important milestone in delivering personalised medicine to breast cancer patients in the NHS; recognises that this test will guide individual decisions about chemotherapy treatment; further notes that avoiding chemotherapy where it is unlikely to be beneficial could improve patient outcomes, reduce overtreatment and save the NHS between
This motion has been signed by a total of 49 MPs.
Download raw data as csv or xml.